Bausch Health Companies (BHC) Income from Non-Controlling Interests (2013 - 2026)

Bausch Health Companies' (BHC) quarterly Income from Non-Controlling Interests came in at -$8.0 million in Q1 2026, up 71.43% year-on-year from -$4.7 million in Q1 2025, and down 188.89% quarter-over-quarter from $9.0 million in Q4 2025.

Bausch Health Companies (BHC) Income from Non-Controlling Interests (2013 - 2026) Analysis & Trends

Bausch Health Companies has disclosed Income from Non-Controlling Interests across 14 years of filings, most recently posting -$8.0 million for Q1 2026.

  • Income from Non-Controlling Interests for Q1 2026 came in at -$8.0 million, up 71.43% year-over-year; the trailing twelve-month figure through Mar 2026 was -$17.0 million (up 58.54% YoY), and the FY2025 annual result was -$37.0 million, down 42.31% from the prior year.
  • Income from Non-Controlling Interests came in at -$8.0 million for Q1 2026 at Bausch Health Companies, down from $9.0 million in the prior quarter.
  • In the past five years, Income from Non-Controlling Interests ranged from a high of $9.0 million in Q4 2025 to a low of -$28.0 million in Q1 2025.
  • The 5-year median for Income from Non-Controlling Interests is -$5.5 million (2023), against an average of -$4.8 million.
  • Across the five-year window, Income from Non-Controlling Interests surged 200.0% in 2022 and slumped 1200.0% in 2024, its largest moves.
  • Bausch Health Companies' Income from Non-Controlling Interests stood at $4.0 million in 2022, then slumped by 300.0% to -$8.0 million in 2023, then surged by 162.5% to $5.0 million in 2024, then jumped by 80.0% to $9.0 million in 2025, then slumped by 188.89% to -$8.0 million in 2026.
  • The last three Income from Non-Controlling Interests figures came in at -$8.0 million (Q1 2026), $9.0 million (Q4 2025), and $2.0 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inc. Minority (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn -
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn -
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn -
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn 22.56 Mn
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn -
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn -
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn -
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn -
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn -
10 Bausch Health Companies 1.91 Bn 1.58 Bn 2.48 Bn -8.00 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -8.00 Mn
Dec 31, 2025 9.00 Mn
Sep 30, 2025 2.00 Mn
Jun 30, 2025 -20.00 Mn
Mar 31, 2025 -28.00 Mn
Dec 31, 2024 5.00 Mn
Sep 30, 2024 -7.00 Mn
Jun 30, 2024 -11.00 Mn
Mar 31, 2024 -13.00 Mn
Dec 31, 2023 -8.00 Mn
Sep 30, 2023 -4.00 Mn
Jun 30, 2023 1.00 Mn
Mar 31, 2023 -8.00 Mn
Sep 30, 2022 4.00 Mn
Jun 30, 2022 6.00 Mn
Mar 31, 2022 3.00 Mn
Dec 31, 2021 3.00 Mn
Sep 30, 2021 3.00 Mn
Jun 30, 2021 2.00 Mn
Mar 31, 2021 3.00 Mn